Stock listing
OTC:MRZM Marizyme, Inc. Stock
Follow Marizyme, Inc. into a list and get an email when it puts out news.
Share price · OTC:MRZM
$0.0003 USD 0.0000 (0.0%)
Close on Nov 19, 2026 · Data provided by Twelve Data
- Day range
- $0.0003 – $0.0003 USDNov 19, 2026
- Market cap
- —Left out: price × shares is far from the company's reported size
- 52-week range
- $0.0003 – $0.0003 USDLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
- Traded on an average day
- $0 USDMedian day 0 shares · 66 days with no trades · last 3 months, Aug 19, 2026 – Nov 19, 2026

Daily closes
Last 3 months, Aug 19, 2026 – Nov 19, 2026 · OTC:MRZM · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 |
- Ticker
- OTC:MRZM
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- OTC
- Currency
- USD
Latest news
Marizyme, Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 30 in all · newest Apr 16, 2024 · oldest 2019
- Decks
- 6 decks · latest Feb 26, 2021
Valuation
price Nov 19, 2026
- Enterprise value
- No market cap
- P/E
- No market cap
- EV/sales
- No market cap
- EV/EBITDA
- No market cap
- Price/book
- No market cap
- Gross margin
- No statements on 6ix yet
- Operating margin
- No statements on 6ix yet
- Net margin
- No statements on 6ix yet
- Debt to equity
- No statements on 6ix yet
- Beta vs S&P 500
- 0.00
Team and board
Officers
| Officer | Role |
|---|---|
| David Barthel | Chief Executive Officer & Director |
| Amar Dhaduk | Director of Business Development & Commercial Operations |
| Cheryl Rosenberger | Director, Technical Operations |
| Joe Paparella | Director of Quality Assurance & Regulatory Affairs |
| Marco Barron | Director of Clinical & Global Operations |
Board
| Director | Role |
|---|---|
| David Barthel | Chief Executive Officer & Director |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| 2021 BIOTECH Showcase at J.P. Morgan Healthcare Conference Week | Conference | 35 slides | Feb 26, 2021 |
| Biotech Showcase 2021 | Conference | 9 slides | Feb 26, 2021 |
| GBS Enterprises — Investor Presentation (November 2011) | Investor deck | 24 slides | Nov 8, 2011 |
| GBS Enterprises — Investor Presentation (September 2011) | Investor deck | 14 slides | Sep 14, 2011 |
| GBS Enterprises — Investor Presentation (June 2011) | Investor deck | 13 slides | Jun 6, 2011 |
| GBS Enterprises — Investor Presentation (March 2011) | Investor deck | 13 slides | Mar 11, 2011 |
Cap table
Built by 6ix from Marizyme, Inc.’s releases
- Common shares
- 131,793,088
- Fully diluted
- 131,793,088
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 131,793,088 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 131,793,088 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James Sapirstein Other companies: INmune Bio Inc. (Director · Since at least Sep 8, 2026); Cocrystal Pharma, Inc. (Chief Executive Officer · Since at least Jun 3, 2026); ZyVersa Therapeutics, Inc. (Chairman and CEO – 8 Prime Biosciences · Since at least Jan 5, 2023); Onconetix, Inc. (Director · Feb 23, 2022 – Sep 26, 2024 · Past); Blue Water Acquisition Corp (Director · Dec 15, 2020 – Dec 15, 2020 · Past); GridAI Technologies Corp. (Chairman and CEO, Director · Oct 8, 2019 – Jul 2, 2024 · Past); Lunai Bioworks Inc. (Director · Mar 6, 2018 – Jun 25, 2024 · Past); ProBility Media Corp. (Director · Nov 8, 2016 – Feb 15, 2017 · Past); RespireRx Pharmaceuticals Inc (Director · Mar 31, 2016 – Dec 9, 2017 · Past); Hepion Pharmaceuticals, Inc. (Chief Executive Officer, Director · Mar 19, 2014 – Jan 3, 2018 · Past) | Interim CEO, Director · Sep 10, 2020 – Mar 5, 2021 · Past |
| Bruce Harmon Other companies: Idaho Copper Corporation (Chief Financial Officer · Since at least Jul 28, 2026); Onconetix, Inc. (Chief Financial Officer · Oct 4, 2023 – Oct 4, 2023 · Past); Green Innovations Ltd (Director · May 16, 2013 – Dec 31, 2014 · Past) | CFO · Sep 1, 2020 – Oct 22, 2020 · Past |
| Michael R Stewart Other companies: STRATA Skin Sciences, Inc. (President & CEO, Director · Feb 25, 2016 – Feb 25, 2016 · Past); MELA Sciences Inc (President & CEO · Aug 1, 2014 – Dec 15, 2015 · Past); PhotoMedex Inc (PHMD) (Director · Mar 10, 2006 – May 17, 2017 · Past) | Director · Jun 1, 2022 – Jun 7, 2022 · Past |
| Satishchandran Chandrasekhar Other companies: Ocugen, Inc. (Director · Since at least Jun 5, 2025); Statera Biopharma, Inc. (Director · Feb 22, 2022 – Feb 22, 2022 · Past) | Chief Operating Officer · Jul 31, 2020 – Jul 31, 2020 · Past |
| Julie Kampf Other companies: Jupiter Neurosciences, Inc. (Director · Since at least Nov 8, 2024) | Director · Mar 5, 2021 – Jun 7, 2022 · Past |
| Neil J Campbell Other companies: Onconetix, Inc. (Chief Executive Officer, Director · Oct 4, 2023 – Oct 4, 2023 · Past) | Chief Executive Officer, Director · Nov 1, 2020 – Nov 1, 2020 · Past |
| Vithalbhai D Dhaduk Other companies: FNCB Bancorp Inc (Director · Sep 27, 2017 – Mar 15, 2021 · Past) | Chairman of the Board, Director · Feb 22, 2021 – Apr 14, 2023 · Past |
| Amar Dhaduk | Director of Business Development & Commercial Operations · Since at least Nov 4, 2026 |
| Bradley Richmond | Acting VP of Finance · Jul 19, 2021 – Jul 19, 2021 · Past |
| Catherine J Pachuk | Chief Science Officer · Jul 31, 2020 – Jul 31, 2020 · Past |
All 23 people
| Person | Seat |
|---|---|
| Cheryl Rosenberger | Director, Technical Operations · Since at least Nov 4, 2026 |
| David Barthel | Chief Executive Officer & Director · Since at least Nov 10, 2021 |
| Donald Leroy Very Jr | Executive Vice President · Nov 1, 2020 – Nov 1, 2020 · Past |
| Georgiy Kovalyov | Chief Financial Officer · Dec 21, 2021 – Mar 17, 2022 · Past |
| Harrison Ross | Vice President of Finance · Dec 21, 2021 – Mar 17, 2022 · Past |
| Joe Paparella | Director of Quality Assurance & Regulatory Affairs · Since at least Nov 4, 2026 |
| Juan Francisco Gutierrez | Director · Nov 11, 2018 – Nov 11, 2018 · Past |
| Marco Barron | Director of Clinical & Global Operations · Since at least Nov 4, 2026 |
| Nicholas DeVito | Interim CEO, Interim CFO · Jul 13, 2019 – Jul 13, 2019 · Past |
| Nilesh Umedbhai Patel | Director · Apr 22, 2022 – Jun 7, 2022 · Past |
| Steven Scott Brooks | Chief Medical Officer · Jul 28, 2020 – Jul 28, 2020 · Past |
| Terry A Brostowin | Director · Sep 10, 2020 – Jun 7, 2022 · Past |
| William Hearl | Director · Jun 7, 2022 – Jun 7, 2022 · Past |
Log in to ask 6ix AI your own questions about Marizyme, Inc.